Microsoft stock dips as new data-center “power bill” pledge lands ahead of earnings

Microsoft stock dips as new data-center “power bill” pledge lands ahead of earnings

New York, January 13, 2026, 09:34 EST — Regular session

  • Microsoft shares dipped early Tuesday following the launch of a U.S. data-center plan targeting electricity and water consumption
  • The move responds to growing resistance from communities and policymakers over AI-era infrastructure costs
  • Investors eye Microsoft’s Jan. 28 earnings, seeking clues on Azure demand and AI investment

Microsoft Corp shares slipped in early trading Tuesday following the release of a plan designed to prevent its U.S. data centers from driving up local power costs and to increase transparency on water usage. The stock fell $2.06, or roughly 0.4%, to $477.18.

The data-center buildout hits the core of investor concerns about Microsoft: how quickly it can ramp up cloud and AI capacity without ballooning costs or facing pushback from local communities.

This matters because the leading players in AI are also the top consumers of power, land, and equipment. When electricity costs climb, it quickly becomes a political hot potato. Add utilities and regulators into the mix, and it turns into a clear margin concern.

Microsoft announced it will cover its electricity costs by paying utility rates and collaborate with local power providers to boost supply and upgrade grid infrastructure as necessary for its data centers. The company also committed to replenishing more water than its facilities use and will release water-use data for each U.S. data-center region. (Reuters)

Microsoft President Brad Smith told Axios the company is “not asking taxpayers to subsidize our electricity costs,” stressing it is “definitely not asking consumers to pay” via their bills. He also highlighted commitments to avoid seeking local tax breaks and to finance training programs linked to data-center jobs. (Axios)

The drive for companies to “pay their own way” comes as investors weigh whether the AI infrastructure race will generate returns quickly enough to justify the costs. BlackRock noted that clients seeking AI exposure into 2026 are favoring energy and infrastructure firms instead of the largest tech giants. Ibrahim Kanan, head of core U.S. equity at BlackRock, emphasized that it’s “increasingly important to risk-manage megacap and AI exposure.” (Reuters)

Macro factors are in play as well. On Tuesday, U.S. data revealed core consumer prices—the gauge excluding food and energy—climbed just 0.2% in December, below economists’ forecasts. This softer reading bolsters bets that the Federal Reserve could cut rates later this year, which typically boosts long-duration tech stocks. (Reuters)

On the Street, sentiment remains generally positive but with some variation. Barclays analyst Raimo Lenschow maintained an “Overweight” rating on Microsoft, though he lowered his price target to $610 from $625, according to a note summary on GuruFocus. (GuruFocus)

Traders are now weighing if the data-center commitment genuinely shifts the economics of growth, or simply rearranges payment timing and recipients. While power contracts, grid upgrades, and water limits evolve slowly, their impact often surfaces in capex budgets and company forecasts.

The plan also flags a risk: community resistance and stricter regulations might slow projects or hike operating expenses, even if demand for cloud and AI remains strong. Any hint of slower capacity expansion would draw scrutiny, considering Azure’s key part in Microsoft’s growth strategy.

Microsoft is set to release its fiscal 2026 second-quarter earnings after the market close on Wednesday, Jan. 28. The company will hold a conference call at 2:30 p.m. Pacific Time. (Source)

Stock Market Today

  • ACADIA Pharmaceuticals Seen as Undervalued Despite Recent Rebound, DCF Model Shows
    February 2, 2026, 10:21 PM EST. ACADIA Pharmaceuticals (NASDAQ: ACAD) shares trade around $26, showing a mixed return profile: roughly flat year-to-date, up 41.2% over the past year, yet down 49% versus five years ago. The stock currently trades at a price-to-earnings (P/E) ratio of 16.9x, below the biotech industry average of 20.3x, signaling market caution. However, a discounted cash flow (DCF) model using a two-stage free cash flow to equity approach estimates ACADIA's intrinsic value at $140.47 per share, suggesting an 81.4% undervaluation. The model factors in projected free cash flow growth from $142.7 million over the past 12 months to an estimated $780 million by 2030. These projections highlight potential long-term value despite near-term volatility. Investors should weigh these valuations against sector risks and company fundamentals before making decisions.
Apple stock today: Google Gemini-Siri tie-up puts AAPL back in the AI spotlight
Previous Story

Apple stock today: Google Gemini-Siri tie-up puts AAPL back in the AI spotlight

IREN stock rises again as Bernstein’s “top AI pick” call meets a bitcoin rebound
Next Story

IREN stock rises again as Bernstein’s “top AI pick” call meets a bitcoin rebound

Go toTop